Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 453781 - 453800 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Sweden | (J05AF05) lamivudine (adm: O) | Epivir® | 30, 300 mg , Burk, 30 tabletter (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | OrifarmAB |
| Sweden | (J05AF05) lamivudine (adm: O) | Epivir® | 30, 300 mg , Burk, 30 tabletter (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | MedartuumAB |
| Sweden | (J05AF05) lamivudine (adm: O) | Epivir® | 30, 300 mg , Burk, 30 tabletter (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | ParanovaLäkemedelAB |
| Sweden | (J05AF05) lamivudine (adm: O) | Lamivudine Teva Pharma BV | 30, 300 mg , Burk, 30 tabletter (PD Ebb Medical AB) | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | EbbMedicalAB |
| Sweden | (J05AF05) lamivudine (adm: O) | Lamivudine Teva Pharma BV | 30, 300 mg , Burk, 30 tabletter (PD Orifarm) | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | OrifarmAB |
| Sweden | (J05AF05) lamivudine (adm: O) | Lamivudine Teva Pharma BV | 30, 300 mg , Burk, 30 tabletter (PD 2care4 ApS) | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | 2care4ApS |
| Sweden | (J05AF06) abacavir (adm: O) | Ziagen® | 60, 300 mg , Blister, 60 tabletter | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | GlaxoSmithKlineAB |
| Sweden | (J05AF06) abacavir (adm: O) | Ziagen® | 60, 300 mg , Blister, 60 tabletter (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | OrifarmAB |
| Sweden | (J05AF07) tenofovir disoproxil (adm: O) | Viread® | 30, 245 mg , Burk, 30 tabletter (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic; HIV Infections | ParanovaLäkemedelAB |
| Sweden | (J05AF10) entecavir (adm: O) | Baraclude® | 30, 0,5 mg , Blister, 30 x 1 tabletter (PD Paranova Läkemedel AB) (endos) | Retail price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic | ParanovaLäkemedelAB |
| Sweden | (J05AF10) entecavir (adm: O) | Baraclude® | 30, 0,5 mg , Blister, 30 x 1 tabletter (PD Orifarm AB) (endos) | Retail price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic | OrifarmAB |
| Sweden | (J05AF10) entecavir (adm: O) | Baraclude® | 30, 0,5 mg , Blister, 30 x 1 tabletter (PD 2 Care 4) (endos) | Retail price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic | 2care4ApS |
| Sweden | (J05AF10) entecavir (adm: O) | Entekavir Ebb | 90, 0,5 mg , Blister, 90 tabletter | Retail price without vat |
$0-0 |
$0-0 |
n/a | EbbMedicalAB |
| Sweden | (J05AF10) entecavir (adm: O) | Baraclude® | 30, 1 mg , Blister, 30 x 1 tabletter (PD Paranova Läkemedel AB) (endos) | Retail price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic | ParanovaLäkemedelAB |
| Sweden | (J05AF10) entecavir (adm: O) | Baraclude® | 30, 1 mg , Blister, 30 x 1 tabletter (PD 2 Care 4) (endos) | Retail price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic | 2care4ApS |
| Sweden | (J05AG01) nevirapine (adm: O) | Viramune | 30, 400 mg , Blister, 30 tabletter (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | MedartuumAB |
| Sweden | (J05AG01) nevirapine (adm: O) | Viramune | 30, 400 mg , Blister, 30 tabletter (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | OrifarmAB |
| Sweden | (J05AG01) nevirapine (adm: O) | Viramune | 90, 400 mg , Blister, 90 tabletter | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | BoehringerIngelheimAB |
| Sweden | (J05AG01) nevirapine (adm: O) | Viramune | 30, 400 mg , Burk, 30 tabletter | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | BoehringerIngelheimAB |
| Sweden | (J05AG01) nevirapine (adm: O) | Viramune | 30, 400 mg , Blister, 30 tabletter | Retail price without vat |
$0-0 |
$0-0 |
HIV Infections | BoehringerIngelheimAB |
Pages
